Does GEMFIBROZIL Cause Hypertriglyceridaemia? 34 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Hypertriglyceridaemia have been filed in association with GEMFIBROZIL (Gemfibrozil). This represents 3.1% of all adverse event reports for GEMFIBROZIL.
34
Reports of Hypertriglyceridaemia with GEMFIBROZIL
3.1%
of all GEMFIBROZIL reports
4
Deaths
31
Hospitalizations
How Dangerous Is Hypertriglyceridaemia From GEMFIBROZIL?
Of the 34 reports, 4 (11.8%) resulted in death, 31 (91.2%) required hospitalization, and 4 (11.8%) were considered life-threatening.
Is Hypertriglyceridaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMFIBROZIL. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does GEMFIBROZIL Cause?
Drug hypersensitivity (242)
Drug ineffective (77)
Rhabdomyolysis (63)
Fatigue (60)
Drug interaction (59)
Myalgia (58)
Nausea (54)
Acute kidney injury (52)
Diarrhoea (43)
Rash (41)
What Other Drugs Cause Hypertriglyceridaemia?
PEGASPARGASE (399)
VINCRISTINE (373)
METHOTREXATE (372)
DEXAMETHASONE (358)
CYTARABINE (244)
CYCLOPHOSPHAMIDE (191)
QUETIAPINE (181)
MERCAPTOPURINE (176)
PREDNISONE (161)
DAUNORUBICIN (143)
Which GEMFIBROZIL Alternatives Have Lower Hypertriglyceridaemia Risk?
GEMFIBROZIL vs GEMTUZUMAB OZOGAMICIN
GEMFIBROZIL vs GEMZAR
GEMFIBROZIL vs GENTAMICIN
GEMFIBROZIL vs GEODON
GEMFIBROZIL vs GILENYA